These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33761149)

  • 1. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial.
    Walker N; Smith B; Barnes J; Verbiest M; Parag V; Pokhrel S; Wharakura MK; Lees T; Cubillos Gutierrez H; Jones B; Bullen C
    Addiction; 2021 Oct; 116(10):2847-2858. PubMed ID: 33761149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial.
    Walker N; Calder A; Barnes J; Laking G; Parag V; Bullen C
    BMC Public Health; 2023 Sep; 23(1):1760. PubMed ID: 37697327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking.
    Walker N; Howe C; Bullen C; McRobbie H; Glover M; Parag V; Williman J; Veale R; Nosa V; Barnes J
    BMC Public Health; 2011 Nov; 11():880. PubMed ID: 22104038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
    Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
    Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
    Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
    JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytisine Versus Varenicline for Smoking Cessation in a Primary Care Setting: A Randomized Non-inferiority Trial.
    Oreskovic T; Percac-Lima S; Ashburner JM; Tiljak H; Rifel J; Klemenc Ketiš Z; Oreskovic S
    Nicotine Tob Res; 2023 Aug; 25(9):1547-1555. PubMed ID: 37291049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
    Bullen C; Verbiest M; Galea-Singer S; Kurdziel T; Laking G; Newcombe D; Parag V; Walker N
    BMC Public Health; 2018 May; 18(1):596. PubMed ID: 29728074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytisine versus nicotine for smoking cessation.
    Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
    N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Varenicline and Cytisine for Alcohol Use Reduction Among People With HIV and Substance Use: A Randomized Clinical Trial.
    Tindle HA; Freiberg MS; Cheng DM; Gnatienko N; Blokhina E; Yaroslavtseva T; Bendiks S; Patts G; Hahn J; So-Armah K; Stein MD; Bryant K; Lioznov D; Krupitsky E; Samet JH
    JAMA Netw Open; 2022 Aug; 5(8):e2225129. PubMed ID: 35930287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dogar O; Keding A; Gabe R; Marshall AM; Huque R; Barua D; Fatima R; Khan A; Zahid R; Mansoor S; Kotz D; Boeckmann M; Elsey H; Kralikova E; Parrott S; Li J; Readshaw A; Sheikh A; Siddiqi K;
    Lancet Glob Health; 2020 Nov; 8(11):e1408-e1417. PubMed ID: 33069301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytisine for smoking cessation: A systematic review and meta-analysis.
    Ofori S; Lu C; Olasupo OO; Dennis BB; Fairbairn N; Devereaux PJ; Mbuagbaw L
    Drug Alcohol Depend; 2023 Oct; 251():110936. PubMed ID: 37678096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine preloading for smoking cessation: the Preloading RCT.
    Aveyard P; Lindson N; Tearne S; Adams R; Ahmed K; Alekna R; Banting M; Healy M; Khan S; Rai G; Wood C; Anderson EC; Ataya-Williams A; Attwood A; Easey K; Fluharty M; Freuler T; Hurse M; Khouja J; Lacey L; Munafò M; Lycett D; McEwen A; Coleman T; Dickinson A; Lewis S; Orton S; Perdue J; Randall C; Anderson R; Bisal N; Hajek P; Homsey C; McRobbie HJ; Myers-Smith K; Phillips A; Przulj D; Li J; Coyle D; Coyle K; Pokhrel S
    Health Technol Assess; 2018 Aug; 22(41):1-84. PubMed ID: 30079863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.